Altered cell cycle arrest and gene amplification potential accompany loss of wild-type p53

Cell

Volumn 70, Issue 6, 1992, Pages 923-935

  Livingstone, Laura R ^a,c   White, Alicia ^a,b,c   Sprouse, Jason ^a,c   Livanos, Elizabeth ^a,c   Jacks, Tyler ^b   Tlsty, Thea D ^a,b,c  

^a UNIVERSITY OF NORTH CAROLINA   (United States)

^b UNIVERSITY OF NORTH CAROLINA SCHOOL OF MEDICINE   (United States)

^c MASSACHUSETTS INSTITUTE OF TECHNOLOGY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

PROTEIN P53;

ALLELE; ANIMAL CELL; ARTICLE; CELL CYCLE; CELL GROWTH; CELL TRANSFORMATION; DIPLOIDY; FIBROBLAST; GENE AMPLIFICATION; GROWTH INHIBITION; HUMAN; HUMAN CELL; MOUSE; PRIORITY JOURNAL; TUMOR SUPPRESSOR GENE;

ANIMAL; ASPARTATE CARBAMOYLTRANSFERASE; ASPARTIC ACID; BASE SEQUENCE; CARBAMOYL-PHOSPHATE SYNTHASE (GLUTAMINE-HYDROLYZING); CELL CYCLE; CELLS, CULTURED; CHROMOSOME DELETION; CYTOGENETICS; DIHYDROOROTASE; EMBRYO; FIBROBLASTS; GENE AMPLIFICATION; GENES, P53; GERM CELLS; HETEROZYGOTE; HUMAN; LI-FRAUMENI SYNDROME; MICE; MICE, TRANSGENIC; MOLECULAR SEQUENCE DATA; MULTIENZYME COMPLEXES; MUTATION; PHOSPHONOACETIC ACID; SUPPORT, NON-U.S. GOV'T; SUPPORT, U.S. GOV'T, P.H.S.; TUMOR CELLS, CULTURED;

ANIMALIA;

EID: 0026801062     PISSN: 00928674     EISSN: None     Source Type: Journal    
DOI: 10.1016/0092-8674(92)90243-6     Document Type: Article

References (52)

1. Cloning and expression of the mouse pgk-1 gene and the nucleotide sequence of its promoter
2. Suppression of human colorectal carcinoma cell growth by wild-type p53
3. A locus on chromosome 11p with multiple restriction site polymorphisms
4. Analysis of the gene coding for the murine cellular tumor antigen p53
5. Spontaneous abnormalities in normal fibroblasts from patients with Li-Fraumeni cancer syndrome: aneuploidy and immortalization
6. Tumorigenic transformation of spontaneously immortalized fibroblasts from patients with a familial cancer syndrome
7. A variation in the structure of the protein-coding region of the human p53 gene
8. Expression of wild-type p53 in human A673 cells suppresses tumorigenicity but not growth rate
9. Organization and nucleotide sequence of the 3′ end of the human CAD gene
10. p53 functions as a cell cycle control protein in osteosarcomas
11. Mice deficient for p53 developmentally normal but susceptible to spontaneous tumors
12. Alterations of the p53 gene in nasopharyngeal carcinomas
13. Wild-type p53 can inhibit oncogene-mediated focus formation
14. A genetic model for colorectal tumorigenesis
15. The development of biological diversity and metastatic potential in malignant neoplasms
16. Activating mutations for transformation by p53 produces a gene product from an hsc70-p53 complex with an altered half-life
17. The p53 proto-oncogene can act as a suppressor of transformation
18. Hamster cells with increased rates of DNA amplification, a new phenotype
19. Association of adenovirus early-region 1A proteins with cellular polypeptides
20. Checkpoints: controls that ensure the order of cell cycle events
21. Immunological evidence for the association of p53 with a heat shock protein, hsc70, in p53-plus-ras-transformed cell lines
22. Mutation is required to activate the p53 gene for cooperation with the ras oncogene and transformation
23. p53 mutations in human cancers
24. Rapid spontaneous dihydrofolate reductase gene amplification shown by fluorescence-activated cell sorting
25. Participation of p53 protein in the cellular response to DNA damage
26. Amplification of a gene coding for human T-cell differentiation antigen
27. Wild-type p53 is a cell cycle checkpoint determinant following irradiation
28. The p53 tumour suppressor gene
29. Germ line p53 mutations in a familial syndrome of breast cancer, sarcomas, and other neoplasms
30. Rearrangement of the p53 gene in human osteogenic sarcomas
31. The mdm-2 oncogene product forms a complex with the p53 protein and inhibits p53-mediated transactivation
32. The clonal evolution of tumor cell populations
33. Amplification of a gene encoding a p53-associated protein in human sarcomas
34. Increased incidence of CAD gene amplification in tumorigenic rat lines as an indicator of genomic instability of neoplastic cells
35. Pathogenesis of metastatic disease: implications for current therapy and for the development of new therapeutic strategies
36. Gene amplification: an example of accelerated evolution in tumorigenic cells
37. Germ-line transmission of a mutated p53 gene in a cancer-prone family with Li-Fraumeni syndrome
38. Characterization of mutant p53-hsp72/73 protein-protein complexes by transient expression in monkey COS cells
39. Normal diploid human and rodent cells lack a detectable frequency of gene amplification
40. Differences in the rates of gene amplification in nontumorigenic and tumorigenic cell lines as measured by Luria-Delbrück fluctuation analysis
41. Suppression of gene amplification in human cell hybrids
42. Early dihydrofolate reductase gene amplification events in CHO cells usually occur on the same chromosome arm as the original locus
43. A deadly inheritance
44. Gene amplification causes overproduction of the first three enzymes of UMP synthesis in N-(phosphonacetyl)-L-aspartate-resistant hamster cells
45. The RAD9 gene controls the cell cycle response to DNA damage in Saccharomyces cerevisiae
46. DNA amplification is rare in normal human cells
47. Wild-type p53 restores cell cycle control and inhibits gene amplification in cells with mutant p53 alleles
48. Surveillance epidemiology and end results incidence and mortality data 1973-77
49. Properties of single-step mutants of syrian hamster cell lines resistant to N-(phosphonacetyl)-L-aspartate